BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2012
View Archived Issues
Imipramine blue with doxorubicin improves survival in glioma model
Read More
Positive phase I results presented for Achillion's NS5A inhibitor
Read More
Janssen Pharmaceutica designs new series of compounds for pain
Read More
Scientists at Antoxis disclose novel antioxidant compounds
Read More
XMetA improves experimental hyperglycemia
Read More
hMaxi-K gene transfer appears safe in women with overactive bladder
Read More
Follow-up of AAV2-FIX study patients shows low risk of insertional mutagenesis
Read More
Spanish team discloses new treatments for Huntington's disease
Read More
Canadian researchers present new vaccines for influenza
Read More
Influenza vaccine triggers protective HAI titers against unmatched H5N1 strains
Read More
New treatments for obesity described by Takeda Pharmaceutical
Read More
Novel isoflavones discovered at Nanjing University of Technology
Read More
Hisamitsu Pharmaceutical seeks approval for transdermal oxybutynin in Japan
Read More
Adamas ready to begin phase III studies of memantine/donepezil capsules
Read More
Trimel Pharmaceuticals begins enrollment in phase II Tefina trial
Read More
PCI Biotech enrolls first patient in phase II ENHANCE study of Amphinex
Read More
NovaBay enrolls first patients in phase IIb BAYnovation study
Read More
FDA accepts amendment to Northwest's DCVax-L trial in brain cancer
Read More
Ambit Biosciences and Teva receive IND clearance for CEP-32496
Read More
Spectrum Pharmaceuticals begins Zevalin/motexafin combination study
Read More
Urocortin 2 improves cardiac output in acute decompensated heart failure
Read More
New phase II trial investigates ladostigil in mild cognitive impairment
Read More
Vertex and CCFC fund Canadian research in IBD
Read More
Levotofisopam proof-of-concept trial successfully completed
Read More
FDA approves new administration schedule for BioThrax
Read More
Epodure to begin first U.S. trial for treatment of anemia in dialysis
Read More